Suronacrine
Has weaker anticholinesterase actions that are masked by cholinoceptor blockade
General
Type : Acridine
Chemical_Nomenclature : 9-benzylamino-1,2,3,4-tetrahydroacridin-1-ol maleate \; 1-Acridinol, 1,2,3,4-tetrahydro-9-((phenylmethyl)amino)-
Canonical SMILES : C1CC(C2=C(C3=CC=CC=C3N=C2C1)NCC4=CC=CC=C4)O
InChI : InChI=1S\/C20H20N2O\/c23-18-12-6-11-17-19(18)20(15-9-4-5-10-16(15)22-17)21-13-14-7-2-1-3-8-14\/h1-5,7-10,18,23H,6,11-13H2,(H,21,22)
InChIKey : HERUZAOANPGYSY-UHFFFAOYSA-N
Other name(s) : Suronacrinum,HOE-427,HP-128
MW : 304.386
Formula : C20-H20-N2-O
CAS_number : 104675-35-6
PubChem : 60601
UniChem : HERUZAOANPGYSY-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Target
References (1)
| Title : Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro - Braga_1991_Br.J.Pharmacol_102_909 |
| Author(s) : Braga MF , Harvey AL , Rowan EG |
| Ref : British Journal of Pharmacology , 102 :909 , 1991 |
| Abstract : Braga_1991_Br.J.Pharmacol_102_909 |
| ESTHER : Braga_1991_Br.J.Pharmacol_102_909 |
| PubMedSearch : Braga_1991_Br.J.Pharmacol_102_909 |
| PubMedID: 1649660 |